TABLE I.
The survey questions
| 1 | Please choose one of the following: I am a ... | ||||||
| □ Medical oncologist □ Surgical oncologist □ Radiation oncologist | |||||||
| □ Hematologist □ Other specialist | |||||||
| 2 | I have been practicing medicine for ... | ||||||
| □ 1–5 years □ 6–10 years □ 11–15 years □16–20 years □ >20 years | |||||||
|
| |||||||
| Strongly disagree | Disagree | Neutral | Agree | Strongly agree | |||
| 1 | 2 | 3 | 4 | 5 | |||
|
| |||||||
| 3 | Please rank, on a 5-point scale, the aspects of clinical trials that you consider to be time-constraining | ||||||
| a) | Extra paperwork associated with clinical trials | ||||||
| b) | Finding patients that meet all of the eligibility criteria of a clinical trial | ||||||
| c) | Explaining the clinical trial to the patient | ||||||
| d) | Obtaining informed consent from patients | ||||||
| e) | Additional clinic visits (extended follow-up for clinical trial patients) | ||||||
| f) | Nonstandard scans and scanning frequency | ||||||
| 4. | Please identify the barriers to your participation as a clinical trial investigator | ||||||
| a) | I find the timing of events within trials to be a problem (for example, must start treatment within 3 weeks of diagnosis) | ||||||
| b) | I lack a complete awareness of available trials | ||||||
| c) | I believe that some clinical trials deviate significantly from the standard of care | ||||||
| d) | I think that the process of having third-party quality assurance review for radiation oncology trials is a deterrent | ||||||
| 5. | Please rank which of the following interventions would motivate you to participate in clinical trials | ||||||
| a) | Attendance at an annual conference where new trials are presented and discussed | ||||||
| b) | A regular session held locally reviewing trial protocols | ||||||
| c) | A clinical trial alert system to draw my attention to new trials | ||||||
| d) | A screening log to aid in the accrual of patients | ||||||
| e) | Software that could assist you to plan the journey of a patient on a clinical trial | ||||||
| f) | Work load credits (clinical) allocated to clinical trial participation | ||||||
| g) | Additional payments toward educational activities (for example: meetings where trials are discussed) | ||||||
| h) | A system of academic credits allocated based on accruing patients on clinical trials | ||||||
| 6. | Please state any other interventions that would motivate you to participate in clinical trials | ||||||